AVTV: Pendulum

AVTV features Pendulum, a Biotech Company Pioneering the Next Frontier of Metabolic Health

Written by

Alumni Ventures

Published on

Read

1 min

Pendulum is a biotech company that works to develop revolutionary, safe, and effective products that address imbalances in the microbiome, transforming people’s lives from the inside out.

In this episode of AVTV, join Colleen Cutcliffe, CEO and Co-founder of Pendulum Therapeutics, as she explains how Pendulum is pioneering microbiome science as a foundation of human health, unlocking the power of your gut with evidence-backed probiotics you can’t find anywhere else.


See video policy below.

Estimated View Time: ~6 Minutes

Company Ask: Try Pendulum & Share Your Feedback

It’s estimated that only 12% of Americans are metabolically healthy, which is why Pendulum is pioneering microbiome science as a foundation of human health, unlocking the power of your gut with evidence-backed probiotics you can’t find anywhere else.

Get 20% off your first membership purchase. The discount will be applied at checkout.

AV Funds Invested in Pendulum: Blue Ivy, Mirror Lake, Provo Ventures, Towerview Ventures and Waterman Ventures

Want to learn more?
View all our available funds and secure data rooms, or schedule an intro call.

New to AV?
Sign up and access exclusive venture content.

Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.

These videos feature members of portfolio companies in which certain Alumni Ventures Funds have invested and may contain factual or forward-looking statements of such members. Neither AV nor any of its affiliated companies represents, warrants, or guarantees the accuracy or the completeness of the information. You agree not to rely on the information contained herein for any investment, business, or financial purpose.